What does DR. RUBEN DE GROOTE – UROLOOG do?

DR. RUBEN DE GROOTE – UROLOOG is a specialist medical practice in Sint-Martens-Latem. Private Limited, started on 24 February 2020, 1 establishment.

What is the address of DR. RUBEN DE GROOTE – UROLOOG?

The registered office of DR. RUBEN DE GROOTE – UROLOOG is located at Valerius De Saedeleerlaan 6, 9830 Sint-Martens-Latem.

Is DR. RUBEN DE GROOTE – UROLOOG still active?

Yes. According to the CBE (17 September 2026) DR. RUBEN DE GROOTE – UROLOOG is active, legal situation “Normale toestand”, started on 24 February 2020.

Is DR. RUBEN DE GROOTE – UROLOOG registered on Peppol?

Yes, DR. RUBEN DE GROOTE – UROLOOG is registered on the Peppol network with ID 0208:0744405120.

What is the enterprise number of DR. RUBEN DE GROOTE – UROLOOG?

The enterprise number of DR. RUBEN DE GROOTE – UROLOOG is BE0744405120.

When was DR. RUBEN DE GROOTE – UROLOOG founded?

DR. RUBEN DE GROOTE – UROLOOG was founded on 24 February 2020.

Who are the directors of DR. RUBEN DE GROOTE – UROLOOG?

According to the 2025 annual accounts, the directors of DR. RUBEN DE GROOTE – UROLOOG are: Ruben De Groote.

Is DR. RUBEN DE GROOTE – UROLOOG a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 February 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. RUBEN DE GROOTE – UROLOOG make in 2025?

DR. RUBEN DE GROOTE – UROLOOG posted a profit after taxes of € 407,455 in financial year 2025.

What is the revenue of DR. RUBEN DE GROOTE – UROLOOG?

As a small company, DR. RUBEN DE GROOTE – UROLOOG is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 547,377.

DR. RUBEN DE GROOTE – UROLOOG (Private Limited)

Dossier DR. RUBEN DE GROOTE – UROLOOG, printed on 17 September 2026 from databakkes.be/en/0744405120/dr-ruben-de-groote-uroloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. RUBEN DE GROOTE – UROLOOG from Sint-Martens-Latem, company number BE0744405120, closed financial year 2025 with a result of € 407,455 after tax. For that financial year DR. RUBEN DE GROOTE – UROLOOG recorded a gross margin of € 547,377 and equity of € 1.5 million. Compared with financial year 2024, the result moved from € 379,615 to € 407,455. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 23, 2026.

What it is worth Growing

€ 1.5 million

▲ 39% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 407,455

▲ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 215,024

▲ 22% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.5 million.

People and assets in 2025

Vehicles and equipment

€ 5,095

▼ 38% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 11,471

▲ € 10,543 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,175

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 396,248 Gross margin 2022: € 396,248 First fiscal year in the series	€ 684,405 Gross margin 2023: € 684,405 ▲ 73% vs 2022 (€ 396,248) Favourable step	€ 453,381 Gross margin 2024: € 453,381 ▼ 34% vs 2023 (€ 684,405) Unfavourable step	€ 547,377 Gross margin 2025: € 547,377 ▲ 21% vs 2024 (€ 453,381) Favourable step	▲ 21%
Profit after taxes	€ 301,718 Profit after taxes 2022: € 301,718 First fiscal year in the series	€ 478,074 Profit after taxes 2023: € 478,074 ▲ 58% vs 2022 (€ 301,718) Favourable step	€ 379,615 Profit after taxes 2024: € 379,615 ▼ 21% vs 2023 (€ 478,074) Unfavourable step	€ 407,455 Profit after taxes 2025: € 407,455 ▲ 7% vs 2024 (€ 379,615) Favourable step	▲ 7%
Equity	€ 663,726 Equity 2022: € 663,726 First fiscal year in the series	€ 901,799 Equity 2023: € 901,799 ▲ 36% vs 2022 (€ 663,726) Favourable step	€ 1,045,414 Equity 2024: € 1,045,414 ▲ 16% vs 2023 (€ 901,799) Favourable step	€ 1,452,869 Equity 2025: € 1,452,869 ▲ 39% vs 2024 (€ 1,045,414) Favourable step	▲ 39%
Total debts	€ 2,601 Total debts 2022: € 2,601 First fiscal year in the series	€ 249,764 Total debts 2023: € 249,764 ▲ € 247,162 vs 2022 (€ 2,601) Unfavourable step	€ 3,102 Total debts 2024: € 3,102 ▼ 99% vs 2023 (€ 249,764) Favourable step	€ 13,646 Total debts 2025: € 13,646 ▲ € 10,543 vs 2024 (€ 3,102) Unfavourable step	▲ € 10,543
Cash	€ 430,416 Cash 2022: € 430,416 First fiscal year in the series	€ 416,157 Cash 2023: € 416,157 ▼ 3% vs 2022 (€ 430,416) Unfavourable step	€ 175,626 Cash 2024: € 175,626 ▼ 58% vs 2023 (€ 416,157) Unfavourable step	€ 215,024 Cash 2025: € 215,024 ▲ 22% vs 2024 (€ 175,626) Favourable step	▲ 22%
Land & buildings	-	-	€ 162,344 Land & buildings 2024: € 162,344 First fiscal year in the series	€ 185,619 Land & buildings 2025: € 185,619 ▲ 14% vs 2024 (€ 162,344) Unchanged	▲ 14%
Retained profit	€ 663,626 Retained profit 2022: € 663,626 First fiscal year in the series	€ 901,699 Retained profit 2023: € 901,699 ▲ 36% vs 2022 (€ 663,626) Favourable step	€ 1,045,314 Retained profit 2024: € 1,045,314 ▲ 16% vs 2023 (€ 901,699) Favourable step	€ 1,452,769 Retained profit 2025: € 1,452,769 ▲ 39% vs 2024 (€ 1,045,314) Favourable step	▲ 39%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 240,000 Dividend 2023: € 240,000 Unchanged (€ 0) Unchanged	€ 236,000 Dividend 2024: € 236,000 ▼ 2% vs 2023 (€ 240,000) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 236,000) Unchanged	▼ 100%
Balance sheet total	€ 666,327 Balance sheet total 2022: € 666,327 First fiscal year in the series	€ 1,151,563 Balance sheet total 2023: € 1,151,563 ▲ 73% vs 2022 (€ 666,327) Unchanged	€ 1,048,517 Balance sheet total 2024: € 1,048,517 ▼ 9% vs 2023 (€ 1,151,563) Unchanged	€ 1,466,515 Balance sheet total 2025: € 1,466,515 ▲ 40% vs 2024 (€ 1,048,517) Unchanged	▲ 40%

Key figures of DR. RUBEN DE GROOTE – UROLOOG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. RUBEN DE GROOTE – UROLOOG?

What happened at DR. RUBEN DE GROOTE – UROLOOG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 23, 2026 New annual accounts for financial year 2025: profit of € 407,455 (▲ 7% vs 2024). filed late Source: NBB ↗
Feb 24, 2020 New establishment in Sint-Martens-Latem. KBO
Feb 24, 2020 Start of the company according to the CBE. KBO

In short

From € 301,718 profit in 2022 to € 407,455 profit in 2025.

Paid € 515,802 in corporate taxes since 2022.

Best year ever: 2023, with € 478,074 profit.

Paid out € 476,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. RUBEN DE GROOTE – UROLOOG? We notify you, reason included.

Follow DR. RUBEN DE GROOTE – UROLOOG

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Ruben De Groote

DR. RUBEN DE GROOTE – UROLOOG

Behind DR. RUBEN DE GROOTE – UROLOOG is Ruben De Groote.

See the full network in the app

Directors

According to the 2025 annual accounts

Ruben De Groote

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Valerius De Saedeleerlaan 6

9830 Sint-Martens-Latem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

DR. ELISE DE BLESER - UROLOOG

€ 28,364 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0744.405.120
VAT number: BE 0744.405.120
Registered office: Valerius De Saedeleerlaan 6, 9830 Sint-Martens-Latem
Names & denominations: DR. RUBEN DE GROOTE – UROLOOG
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 February 2020
Peppol: Active · Active since 24 Nov 2023
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗